Navigation Links
Caffeine Therapy Boosts Preemies' Outcomes
Date:11/7/2007

ematurity, Schmidt and her colleagues followed a group of a little more than 2,000 infants from Canada, Australia and the United Kingdom. Apnea literally means the temporary cessation of breathing, and apnea of prematurity is a common condition in premature babies, because their lungs and central nervous system aren't yet properly developed.

The babies in the study all weighed between 500 and 1,250 grams (about 1 to 3 pounds) and were born at an average of 27 weeks' gestation. Half were randomly assigned to receive caffeine therapy, and the other half was given a placebo. According to Schmidt, the dose given to the babies is equivalent to the amount of caffeine in about six cups of coffee.

In 2006, the researchers published initial results early when they found that babies on caffeine therapy were less likely to suffer from bronchopulmonary dysplasia, a common type of lung damage that occurs in premature babies. However, at the time, they also reported that the babies on caffeine were slightly smaller than the babies on placebo, and growth restriction is always a concern in small babies.

In the current study, the researchers reported their findings when the infants reached two years old. They found that 23 percent fewer babies on caffeine therapy had died or developed a neurodevelopmental disability compared to those on placebo.

The incidence of cerebral palsy was 42 percent lower in the caffeine group, and the risk of cognitive delay was 19 percent lower for the caffeine group than the placebo group.

At the two year follow-up, the researchers found no significant differences in height, weight or head circumference.

Schmidt and her colleagues will continue to follow this group of babies and report their findings again when the children are between five and six years old. At that point, they should be able to better assess cognitive and fine motor function, looking for any subtle delays that weren'
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Caffeine Plus Acetaminophen Toxic for Some
2. Caffeine Survey Reveals Most, Least Caffeinated Cities
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. HIV therapy in pregnancy-data support WHO recommendations
5. Family-based treatment more effective than supportive psychotherapy in treating bulimia
6. Trial to Test Gene Therapy for Angina in Women
7. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
8. Aromatherapy Gift Line Sheds Humorous Light on Modern Therapy
9. Chemotherapy may be culprit for fatigue in breast cancer survivors
10. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
11. New Drug No Substitute for Standard Blood-Clot Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Caffeine Therapy Boosts Preemies' Outcomes
Caffeine Therapy Boosts Preemies' Outcomes
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 1For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 2Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 1Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 2Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 3Tailor made HIV AIDS treatment closer to reality 62127 1Tailor made HIV AIDS treatment closer to reality 62127 2